Skip to main content

Table 2 Summary of patient presentation and outcome

From: Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study

Patient Location Size Central Stage Survival Status
1 LUL 2.9   IA Alive Hillar failure, to hospice
2 LUL 1.5   IA Alive No evidence of disease
3 LUL 2.8 Yes IA Alive No evidence of disease
4 RUL 3.5   IA Alive No evidence of disease
5 LLL 2.3   IA Alive No evidence of disease
6 LUL 2.2   IA Alive No evidence of disease
7 LUL 2.3   IA Deceased Hillar and contralateral failure, hospice
8 LUL 2.4 Yes IA Deceased No evidence of disease
9 LUL 1   IA Deceased No evidence of disease
10 LUL 5.5 Yes IB Alive No evidence of disease
11 RUL 4   IB Alive No evidence of disease
12 RUL 4.7 Yes IB Alive No evidence of disease
13 LUL 3   IB Alive No evidence of disease
14 LLL 3.6   IB Alive No evidence of disease
15 RML 4.5 Yes IB Alive No evidence of disease
16 RLL 4.3   IB Deceased Brain metastases, whole brain radiation
17 RML 3.9   IB Deceased No evidence of disease
18 RLL 3.4   IB Deceased No evidence of disease
19 LUL 3.9 Yes IB Deceased No evidence of disease
20 RLL 3.1   IB Deceased No evidence of disease
21 LUL, LUL 1.8, 1.4   IA Alive No evidence of disease
22 RUL 3.2   IA Alive Failure in the same lobe, SABR
23 RUL 2 Yes III Alive No evidence of disease
24 LUL 2   IA Deceased Malignant pleural effusion, hospice
25 LUL 2.2   IA Deceased Failure at primary and supraclavicular, SABR and tarceva
26 RLL 6.6   IB Deceased No evidence of disease
27 RLL 3   IV Deceased No evidence of disease
28 RLL 2.3   III Deceased Failure in abdominal soft tissue, tarceva
29 LLL 2.3   IV Deceased No evidence of disease
30 RUL, RML 4, 1.5   IV Deceased Distant failure in bone, SABR to bone
  1. Therapy at recurrence is noted.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us